Efforts by business leaders to give companies more protections from North Carolina product liability lawsuits appear derailed in the House.
A House panel this week endorsed a Senate measure that previously would have made it harder for people to sue pharmaceutical companies over products if they met federal regulations and warned of side effects. That’s been left out of the new version.
The original measure would have protected any company that designed, manufactured or sold a product that met regulatory standards. The North Carolina Chamber backs such liability protections. Critics say they could prevent consumers from suing years later over previously undiscovered problems.
The bill going to the full House only contains procedures governing contingency fee agreements between the state and private attorneys.
Topics North Carolina
Was this article valuable?
Here are more articles you may enjoy.
Independent Agencies Total About 37,000 in 2026, a Decrease From 2024
Hellman & Friedman Explores Sale of Applied Systems at Up to $10B, Sources Say
Florida OIR Orders Unlicensed RRG to Cease and Desist After Owners Arrested
Florida Agents Appointed With Citizens Drops as Carrier Competition Grows 

